Transradial Closure Devices Market Size & Share, by Product (Band/Strap, Knob, Plate Based); Usage (Disposable Devices, Reusable Devices); Application (Surgical Interventions, Diagnostics); End-user (Hospitals, Ambulatory Surgical Centers, Independent Catheterization Centers, Specialized Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4346
  • Published Date: Feb 14, 2023
  • Report Format: PDF, PPT

Companies Dominating the Transradial Closure Devices Landscape

top-features-companies
    • Medtronic plc

      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Teleflex Incorporated
    • Merit Medical Systems, Inc.
    • Abbott Laboratories
    • Fisher & Paykel Healthcare Corporation Limited
    • Beijing Demax Medical Technology Co., Ltd.
    • Semler Technologies, Inc.
    • Endocor GmbH
    • Morris Innovative, Inc.
    • Transluminal Technologies, LLC 

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Medtronic plc announced the completion of the acquisition of Affera, Inc. With this acquisition, the company expands its cardiac ablation portfolio with the first integrated cardiac mapping and navigation platform that encompasses fully integrated diagnostics, focal pulsed fields, and radiofrequency ablation solutions.

  • Teleflex Incorporated stated it has received Health Canada approval for its MANTA Vascular Closure Device - the first commercially available biomechanical closure device specifically designed for large bore femoral arterial access sites


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4346
  • Published Date: Feb 14, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Worldwide spike in coronary artery disease (CAD), growing prevalence of strokes, escalation of lifestyle diseases, and raising cholesterol levels are some major factors driving the growth of the market in the forecast period.

The market is anticipated to attain a CAGR of 9% over the forecast period, i.e., 2023-2035.

Inadequate knowledge of proper handling of devices, high cost of transradial closure devices, and insufficiency of knowledge about the procedure are estimated to hamper the market growth.

The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Medtronic plc, Teleflex Incorporated, Merit Medical Systems, Inc., Abbott Laboratories, Fisher & Paykel Healthcare Corporation Limited, Beijing Demax Medical Technology Co., Ltd., Semler Technologies, Inc., Endocor GmbH, Morris Innovative, Inc., Transluminal Technologies, LLC, and others.

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product, usage, application, end-user, and by region.

The independent catheterization centers segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying